Safety of stimulant medications for attention deficit hyperactivity disorder in paediatric congenital heart disease.
Lorraine Marie ChungGopakumar HariharanSuraj K VarmaPublished in: Journal of paediatrics and child health (2023)
Stimulant medications are safe in patients with underlying CHD. In mild congenital cardiac conditions (ventricular septal defect, atrial septal defect and isolated semilunar valve disease), paediatricians can safely initiate stimulant therapy. With complex CHD cases, cardiology opinion is recommended prior to starting stimulants.
Keyphrases
- attention deficit hyperactivity disorder
- congenital heart disease
- autism spectrum disorder
- left ventricular
- working memory
- catheter ablation
- mitral valve
- heart failure
- aortic valve
- intensive care unit
- atrial fibrillation
- emergency department
- left atrial
- cardiac surgery
- coronary artery disease
- bone marrow
- thoracic surgery
- replacement therapy